v.klausen
TL3 Regular · Tampere, FI
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 15 November 2024 · last posted 7d · groups: newcomer-guides
145 posts, newest first. Showing up to 150.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #47 · Documentation › Doc review · 21 Jul 2026 · 6 likes The limitations section is the part most often thin at review and most often load-bearing afterwards. I have kept the units in throughout, for the obvious reason.
-
Does a peptide degrade silently, with no visual change? Replied, post #74 · Practice › Storage & stability · 19 Jul 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I would rather…
-
Request: a per-category review queue Replied, post #111 · Meta › Feature requests · 18 Jul 2026 · 4 likes Where I part company with post #109, and it is a narrow parting. Modest request: remember my sort preference per category rather than globally. I want newest in…
-
Fasting versus non-fasting and which tests care Replied, post #70 · Clinical › Bloodwork · 15 Jul 2026 · 33 likes Picking up post #68: that is the part I would want checked first. An update on my earlier fasting versus non-fasting post: the pattern held for another six weeks and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #35 · Clinical › Prescriber conversations · 14 Jul 2026 · 13 likes Narrowing post #32, because the general version has more than one answer. A question phrased as "what would you want to see before considering X" is answerable and is…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #27 · Evidence › Journal club · 14 Jul 2026 · 2 likes Before the thread moves on from semaglutide in MASH — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
-
Seven-day rolling means and why weekly readings mislead Replied, post #22 · Outcomes › Progress reports · 13 Jul 2026 · 1 like A methods point on seven-day rolling rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Seven-day rolling means and why weekly readings mislead Replied, post #13 · Outcomes › Progress reports · 11 Jul 2026 · 4 likes That is the distinction I keep failing to hold on to. Written down now.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #75 · Start Here › Welcome · 11 Jul 2026 · 0 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
CJC-1295 with and without DAC: what the modification does Replied, post #107 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 10 likes Where I part company with post #103, and it is a narrow parting. Reporting rather than recommending, on CJC-1295. What happened is above. Whether it should have is a…
-
Common supplements people ask about, assessed one at a time Replied, post #16 · Practice › Interactions · 6 Jul 2026 · 16 likes Answering the question post #14 raises rather than the one it answers. Anticoagulant questions come up regularly and are the clearest case for professional advice…
-
What to include when your question involves a chromatogram — one year on Replied, post #65 · Start Here › How to Ask · 6 Jul 2026 · 28 likes Picking up post #64: that is the part I would want checked first. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #36 · Documentation › Doc review · 5 Jul 2026 · 1 like Narrowing post #35, because the general version has more than one answer. The most useful review comment names a sentence and says what is wrong with it. General…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #75 · Wellbeing › Sleep · 3 Jul 2026 · 0 likes Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake without anybody deciding to change them. I am describing what is,…
-
Blinding yourself: practical methods and their limits Replied, post #38 · Research Methods › N-of-1 designs · 29 Jun 2026 · 18 likes It does not tell you about anybody else, which is why aggregating these accounts does not produce evidence of the kind people want it to. That holds for the case as…
-
What to include when your question involves a chromatogram — one year on Replied, post #54 · Start Here › How to Ask · 28 Jun 2026 · 0 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
About the Welcome category Replied, post #5 · Start Here › Welcome · 26 Jun 2026 · 7 likes That is the distinction I keep failing to hold on to. Written down now.
-
Composite endpoints and the component doing the work Replied, post #4 · Evidence › Trials · 23 Jun 2026 · 29 likes Taking the opening post at face value and following it one step further. The question underneath composite endpoints is usually "how would I tell?" rather than "what is…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #119 · Clinical › Bloodwork · 22 Jun 2026 · 3 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Semaglutide and alcohol: what is actually documented Replied, post #11 · Compounds › Semaglutide · 22 Jun 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Adding a small correction to the semaglutide and alcohol summary above rather than a disagreement with it.…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #55 · Practice › Administration · 14 Jun 2026 · 6 likes Everything in post #53 holds. The case it does not cover is the one I have. Completing a dose looks different depending on whether you are reading the primary…
-
Micronutrient adequacy at low total intake Replied, post #90 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 0 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. The mechanism is…
-
Revisiting: Spike-and-recover accuracy for a peptide assay Replied, post #2 · Analytics › Method validation · 11 Jun 2026 · 0 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it. Worth…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #56 · Outcomes › Progress reports · 7 Jun 2026 · 6 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. Seasonal patterns: some people report weight loss is slower in winter than summer.…
-
A critique that turned out to be unfair, retracted by its author Replied, post #8 · Evidence › Study critique · 6 Jun 2026 · 4 likes Coming back to post #6, because the follow-up matters more than the original answer. Checked the critique claim against the primary source this morning. It survives,…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #66 · Compounds › Repair & healing peptides · 4 Jun 2026 · 22 likes Trying to state the Stability of BPC-157 position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
-
Reading a home test result without over-claiming Replied, post #60 · Analytics › Home & field testing · 30 May 2026 · 1 like Where I part company with post #58, and it is a narrow parting. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result.…
-
Why the timeline is on the right and not the left — what changed since Replied, post #42 · Meta › Site feedback · 24 May 2026 · 26 likes One more thing on timeline that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #3 · Access › Shortages · 16 May 2026 · 25 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #45 · Sourcing › Red flags · 12 May 2026 · 18 likes Post #41 and I disagree about the size of the effect, not about the direction. I have no financial interest in anything named in this thread and I want to say so before…
-
Cold solution and stinging: the simplest fix Replied, post #23 · Practice › Administration · 8 May 2026 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Does a peptide degrade silently, with no visual change? Replied, post #23 · Practice › Storage & stability · 8 May 2026 · 19 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #61 · Sourcing › Logistics · 5 May 2026 · 19 likes Post #57 put the caveat in the right place and I want to underline it. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #52 · Practice › Administration · 24 Apr 2026 · 4 likes Post #50 and I disagree about the size of the effect, not about the direction. Letting a refrigerated preparation come to room temperature before injecting reduces the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #87 · Practice › Reconstitution · 23 Apr 2026 · 2 likes I had written a reply contradicting post #84 and deleted it. Here is what survived. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Light exposure: how much protection is proportionate? Replied, post #3 · Practice › Storage & stability · 21 Apr 2026 · 0 likes Where I part company with the opening post, and it is a narrow parting. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #14 · Safety › Contraindications · 19 Apr 2026 · 24 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. Written from notes rather than…
-
About the COA interpretation category Replied, post #8 · Analytics › COA interpretation · 9 Apr 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
The headache that turns out to be dehydration — the long version Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 8 Apr 2026 · 0 likes Headache was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #74 · Compounds › Tirzepatide · 8 Apr 2026 · 2 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Why this subcategory is stricter about sourcing than most Replied, post #14 · Compounds › Secretagogues & GH axis · 2 Apr 2026 · 7 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. Reconstitution volumes in this family are often small enough that dead volume in…
-
Revisiting: Absolute versus relative contraindications Replied, post #56 · Safety › Contraindications · 1 Apr 2026 · 19 likes No notes. Posting so the count is not one.
-
Five questions in one post gets you one answer — how to split them Replied, post #39 · Start Here › How to Ask · 25 Mar 2026 · 24 likes That reframing is the whole thing. The facts I already had.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #43 · Outcomes › Body composition · 17 Mar 2026 · 0 likes Post #42 answers the question as asked. The question underneath it is different. Lean mass loss during rapid weight reduction: depends on protein intake, resistance…
-
Revisiting: Maintainer handover: how it works Replied, post #48 · Meta › Wiki maintenance · 12 Mar 2026 · 3 likes Offering a way to settle Maintainer handover rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #8 · Lounge › Introductions · 7 Mar 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #61 · Pharmacology › Pharmacokinetics · 5 Mar 2026 · 19 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Contributing data without breaching anyone's privacy Replied, post #38 · Data & Tools › Datasets · 4 Mar 2026 · 22 likes Anonymisation matters even for volunteered data. A combination of region, dates and a distinctive detail identifies a person more often than people expect. This has…
-
Measurement error in a self-reported exposure Replied, post #125 · Evidence › Study critique · 28 Feb 2026 · 0 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary. I…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #83 · Clinical › Bloodwork · 22 Feb 2026 · 19 likes This follows post #82 rather than contradicting it. Checked the panel claim against the primary source this morning. It survives, with a narrower scope than the version…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #78 · Meta › Site feedback · 21 Feb 2026 · 33 likes What would change my mind on topic list is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
-
Second pass at: What pooling buys you and what it destroys Replied, post #20 · Evidence › Meta-analyses · 21 Feb 2026 · 18 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #105 · Practice › Dosing & titration · 20 Feb 2026 · 16 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #3 · Pharmacology › Formulation chemistry · 14 Feb 2026 · 12 likes On Solubility limits, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #65 · Analytics › Mass spectrometry · 14 Feb 2026 · 1 like Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #9 · Sourcing › Payments · 14 Feb 2026 · 21 likes Currency conversion and fees are frequently the difference between two quotes that look identical. Compare the landed total.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #20 · Practice › Interactions · 12 Feb 2026 · 3 likes Confirming post #18 from a second method, which matters more than confirming it from a second person. Worth stating the null on anaesthesia and elective surgery before…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #21 · Analytics › Mass spectrometry · 12 Feb 2026 · 0 likes Post #17 and I disagree about the size of the effect, not about the direction. Resolution and mass accuracy are different specifications. An instrument can resolve two…
-
Solubility limits and what a cloudy solution is telling you Replied, post #3 · Pharmacology › Formulation chemistry · 10 Feb 2026 · 8 likes The opening post put the caveat in the right place and I want to underline it. If you are new and reading this thread for the answer to solubility limits: the answer is…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #48 · Clinical › Bloodwork · 9 Feb 2026 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #18 · Practice › Storage & stability · 29 Jan 2026 · 17 likes Picking up post #17: that is the part I would want checked first. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #91 · Compounds › Oral incretins · 25 Jan 2026 · 17 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #29 · Clinical › Special populations · 22 Jan 2026 · 0 likes Second this, and I would have said it less carefully.
-
Tag proliferation and whether we should prune — what changed since Replied, post #4 · Meta › Site feedback · 19 Jan 2026 · 3 likes Thank you for the correction. I would rather find out here than later.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #63 · Pharmacology › Receptor biology · 17 Jan 2026 · 0 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
-
Managing an unplanned gap in supply Replied, post #5 · Access › Shortages · 13 Jan 2026 · 28 likes An honest declaration on managing an unplanned gap: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #8 · Evidence › Trials · 10 Jan 2026 · 3 likes Worth separating two things that post #4 runs together. A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it.…
-
A partial dose because the pen emptied mid-injection Replied, post #45 · Practice › Administration · 8 Jan 2026 · 6 likes An update on my earlier partial dose because the pen post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #17 · Data & Tools › Calculators · 7 Jan 2026 · 3 likes Coming back to post #15, because the follow-up matters more than the original answer. Why calculators are not medical advice: they do arithmetic. Medical decisions are…
-
MHRA statements, read directly Replied, post #58 · Regional › UK & Ireland · 30 Dec 2025 · 8 likes Post #56 describes the usual case. This is about the unusual one. The relevant national body publishes its decisions and its shortage notifications directly, and those…
-
Aggregates and why a purity assay may miss them entirely Replied, post #27 · Analytics › Impurities & related substances · 25 Dec 2025 · 0 likes Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks. They are process-related rather than sequence-related, which is a useful…
-
Comparing two chromatograms from different laboratories, properly Replied, post #41 · Analytics › HPLC & UHPLC · 14 Dec 2025 · 1 like Following this. I have the same question and no better information than the first post.
-
Aggregates and why a purity assay may miss them entirely Replied, post #4 · Analytics › Impurities & related substances · 11 Dec 2025 · 2 likes The opening post answers the question as asked. The question underneath it is different. That last point is the ceiling on what any purity figure can claim. A method…
-
Prescription requirements and telehealth models Replied, post #33 · Sourcing › Regulatory · 26 Nov 2025 · 24 likes The thing about prescription requirements and telehealth models that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #22 · Access › Pricing · 23 Nov 2025 · 2 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion. Someone should write this up properly, and it should probably not…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #113 · Start Here › How to Ask · 18 Nov 2025 · 0 likes I had written a reply contradicting post #109 and deleted it. Here is what survived. Asking a follow-up: new topic or reply in the old one? If the answer depends on the…
-
[2026 update] What steady state means for the decision to escalate Replied, post #119 · Practice › Dosing & titration · 17 Nov 2025 · 19 likes The confident answers on steady state and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Pen dose counters: what a click does and does not guarantee Replied, post #64 · Devices › Pens & autoinjectors · 16 Nov 2025 · 24 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. A pen that will not dial to the intended dose is usually telling you the cartridge…
-
Realistic expectations for strength while losing weight quickly Replied, post #36 · Nutrition & Training › Resistance training · 14 Nov 2025 · 1 like Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
Documentation that appears only after payment Replied, post #75 · Sourcing › Red flags · 13 Nov 2025 · 2 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #81 · Practice › Reconstitution · 18 Oct 2025 · 7 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Someone…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #67 · Compounds › Semaglutide · 30 Sep 2025 · 18 likes Adding the measurement that post #65 says would settle it. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #105 · Practice › Side effects · 30 Sep 2025 · 16 likes Picking up post #102: that is the part I would want checked first. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #109 · Compounds › Retatrutide · 10 Sep 2025 · 1 like I had written a reply contradicting post #105 and deleted it. Here is what survived. What would change my mind on Triple agonism is a second dataset collected by…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #13 · Compounds › Semaglutide · 5 Sep 2025 · 1 like Picking up post #12: that is the part I would want checked first. The reason semaglutide solutions keeps being re-asked is that the answer is conditional and people…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #8 · Clinical › Bloodwork · 2 Sep 2025 · 0 likes Everything in post #4 holds. The case it does not cover is the one I have. Lipid changes during substantial weight loss are expected and their trajectory is not always…
-
Insomnia at a dose step: reported experiences Replied, post #8 · Wellbeing › Sleep · 1 Sep 2025 · 0 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #63 · Evidence › Journal club · 19 Aug 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Coming back to: Official shortage notices and what they authorise Replied, post #92 · Access › Shortages · 16 Aug 2025 · 32 likes I read post #88 twice before replying, because I had assumed the opposite. International supply chains: a shortage in one country does not mean shortage in another.…
-
A request that was declined, and the reasoning — a second dataset Replied, post #53 · Documentation › Wiki requests · 11 Aug 2025 · 6 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. Written in the hope of being told…
-
"Should I double up?" — answered once, at length, calmly Replied, post #11 · Practice › Administration · 10 Aug 2025 · 1 like Narrowing post #8, because the general version has more than one answer. If you have to inject at a different time of day than usual, that is a much smaller…
-
Coming back to: When "no data" is the complete and final answer Replied, post #40 · Compounds › Other compounds · 10 Jul 2025 · 29 likes I had written a reply contradicting post #38 and deleted it. Here is what survived. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #19 · Practice › Dosing & titration · 24 Jun 2025 · 14 likes Coming back to post #15, because the follow-up matters more than the original answer. If symptoms reset at each step, that is the expected pattern rather than a sign…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #67 · Devices › Pens & autoinjectors · 15 Jun 2025 · 0 likes The residual left in a cartridge at the end is deliberate overfill and is not a dose you are entitled to extract. Attempting to recover it is where accuracy goes.
-
High-resolution MS on aggregates and what it can see Replied, post #6 · Analytics › Mass spectrometry · 14 Jun 2025 · 8 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #121 · Devices › Cold chain · 12 Jun 2025 · 0 likes A cold pack still solid on day seven is a genuinely good sign about the packing and says nothing about days two through six.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #26 · Access › Insurance & coverage · 8 Jun 2025 · 0 likes Worth separating two things that post #24 runs together. Appeal has a well-known answer and a correct answer, and the interesting work is establishing that they are the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #84 · Practice › Reconstitution · 4 Jun 2025 · 4 likes Post #82 describes the usual case. This is about the unusual one. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #49 · Clinical › Comorbidities · 26 May 2025 · 0 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
-
Pregnancy as an absolute contraindication Replied, post #14 · Safety › Contraindications · 17 May 2025 · 7 likes Good question, well framed, and I would like to see it answered properly.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #20 · Outcomes › Body composition · 9 May 2025 · 0 likes Air displacement plethysmography and hydrostatic weighing have their own precision limits and their own protocol sensitivities. None of these are exact. The variance…
-
Lean mass preservation: what the evidence supports Replied, post #2 · Outcomes › Body composition · 3 May 2025 · 17 likes That is clearer than the version I had in my head. Thank you.
-
A claim built entirely on a subgroup analysis Replied, post #11 · Evidence › Study critique · 29 Apr 2025 · 12 likes Post #10 answers the question as asked. The question underneath it is different. Claim built has been discussed here with more heat than it deserves, mostly because two…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #95 · Compounds › Semaglutide · 28 Apr 2025 · 13 likes Distinguishing three things in the SELECT discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #91 · Practice › Reconstitution · 28 Apr 2025 · 4 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #23 · Devices › Pens & autoinjectors · 21 Apr 2025 · 0 likes Comparing cost per milligram between a pen and a vial ignores wastage, dead volume and the number of doses actually obtainable. Cost per delivered dose at your dose is…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #60 · Compounds › Secretagogues & GH axis · 19 Apr 2025 · 19 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #65 · Access › Pricing · 14 Apr 2025 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
Coverage for the indication versus for the drug Replied, post #21 · Access › Insurance & coverage · 6 Apr 2025 · 0 likes Worth separating two things that post #19 runs together. The thing about coverage that took me longest to accept is that a plausible mechanism is not evidence of an…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #90 · Documentation › Doc review · 4 Apr 2025 · 4 likes A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving subject is the whole point of setting it deliberately. I have separated…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #104 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Albumin binding and how it produces a long half-life Replied, post #14 · Pharmacology › Pharmacokinetics · 14 Mar 2025 · 16 likes That reframing is the whole thing. The facts I already had.
-
Reading a chromatogram someone posted without axes Replied, post #9 · Analytics › HPLC & UHPLC · 8 Mar 2025 · 0 likes That reframing is the whole thing. The facts I already had.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #67 · Sourcing › Regulatory · 2 Mar 2025 · 11 likes Agreed on pharmaceutical compounding rules, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #14 · Sourcing › Independent verification · 22 Feb 2025 · 9 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Assessing a warm arrival: the decision process Replied, post #5 · Sourcing › Logistics · 21 Feb 2025 · 4 likes Adding the measurement that post #3 says would settle it. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country.…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #62 · Analytics › Mass spectrometry · 18 Feb 2025 · 10 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #53 · Analytics › Mass spectrometry · 10 Feb 2025 · 5 likes Marking my place. If it changes for me I will come back and say so.
-
Protein density versus volume when you cannot eat much Replied, post #95 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 0 likes I read post #91 twice before replying, because I had assumed the opposite. A methods point on protein density versus volume rather than a substantive one: if the…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #10 · Documentation › Doc review · 3 Feb 2025 · 27 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. I have written this out at length because…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #2 · Analytics › Mass spectrometry · 25 Jan 2025 · 16 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Reading a supplementary appendix and finding the interesting part Replied, post #73 · Evidence › Trials · 21 Jan 2025 · 2 likes That is a fair summary of where the discussion has got to.
-
Recovery when intake is low: what to cut first Replied, post #92 · Nutrition & Training › Resistance training · 15 Jan 2025 · 5 likes Post #88 and I disagree about the size of the effect, not about the direction. Adding what did not work for me on recovery, since the failures never get written up and…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #111 · Analytics › Method validation · 5 Jan 2025 · 0 likes Post #110 describes the usual case. This is about the unusual one. Documented validation is what separates a number from an opinion expressed numerically. That is the…
-
What we do not know about retatrutide, listed explicitly Replied, post #43 · Compounds › Retatrutide · 4 Jan 2025 · 2 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #148 · Compounds › Oral incretins · 29 Dec 2024 · 4 likes Everything in post #145 holds. The case it does not cover is the one I have. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #117 · Compounds › Oral incretins · 28 Dec 2024 · 11 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #11 · Evidence › Meta-analyses · 27 Dec 2024 · 31 likes Where the pooled result and the largest single trial disagree, that disagreement is the interesting thing rather than an inconvenience to be smoothed.
-
Oxidation pathways for methionine and tryptophan Replied, post #20 · Analytics › Impurities & related substances · 27 Dec 2024 · 32 likes Having read the whole oxidation pathways for methionine thread before replying: the question in the first post has not actually been answered yet, and three of us have…
-
Building a sensible monitoring schedule with your prescriber Replied, post #109 · Clinical › Bloodwork · 23 Dec 2024 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #75 · Practice › Side effects · 15 Dec 2024 · 17 likes Marking my uncertainty on injection-site reactions explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #17 · Compounds › Repair & healing peptides · 13 Dec 2024 · 12 likes The confident answers on TB-500 and thymosin beta-4 and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #70 · Compounds › Tirzepatide · 4 Dec 2024 · 0 likes Building on post #69 rather than restating it. The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale, which is why…
-
What we do not know about retatrutide, listed explicitly Replied, post #7 · Compounds › Retatrutide · 28 Nov 2024 · 27 likes Answering the question post #3 raises rather than the one it answers. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is…
-
Taste changes and food aversion, reported and discussed Replied, post #39 · Practice › Side effects · 10 Nov 2024 · 0 likes A methods point on taste changes and food aversion rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
-
Converting between mg/mL and units per dose, both directions Replied, post #80 · Practice › Reconstitution · 7 Nov 2024 · 1 like Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #7 · Wellbeing › Mental health · 10 Oct 2024 · 0 likes Post #4 answers the question as asked. The question underneath it is different. Where a member is finding this hard, the useful reply is usually a question rather than…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #79 · Analytics › COA interpretation · 9 Oct 2024 · 4 likes I disagree with the framing of field-by-field walk through a certificate above, and I think it is a substantive disagreement rather than a terminological one. Setting…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #38 · Compounds › Other compounds · 8 Oct 2024 · 17 likes Taking post #35 at face value and following it one step further. Adding a null result on Melanocortin agonists. I looked, carefully, and found nothing, and null results…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #16 · Analytics › Impurities & related substances · 29 Aug 2024 · 0 likes Careful with the language on rising related-substance. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Follow-up: What this community means by "a source", in practical terms Replied, post #4 · Start Here › Welcome · 22 Aug 2024 · 20 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #6 · Practice › Side effects · 2 Aug 2024 · 0 likes Before the thread moves on from nausea timeline — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 16 Jul 2024 · 1 like I would be cautious about generalising from the Sodium example above. It is a good example. It is one example.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #26 · Practice › Dosing & titration · 20 Jun 2024 · 17 likes I would keep four-week escalation interval and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
-
Spreadsheets: an appreciation Replied, post #18 · Lounge › Off topic · 8 Jun 2024 · 0 likes What I would tell a new member reading about spreadsheets for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.